Detalhe da pesquisa
1.
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
Br J Dermatol
; 190(3): 355-363, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846976
2.
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
J Eur Acad Dermatol Venereol
; 37(12): 2517-2525, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625815
3.
Hospitalization in Patients with Psoriasis: Impact of Biological Therapies on Temporal Evolution.
J Drugs Dermatol
; 20(2): 208-214, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538560
4.
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.
Dermatol Ther
; 33(6): e14066, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713119
5.
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients.
J Eur Acad Dermatol Venereol
; 38(1): e26-e28, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561934
6.
Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study.
Dermatol Ther
; 35(11): e15831, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109488
7.
An 18-Month Follow-Up of Digital Myxoid Cysts After Therapy With Percutaneous Sclerotherapy With Polidocanol.
Dermatol Surg
; 44(1): 140-142, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323655
8.
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1).
Dermatol Ther (Heidelb)
; 13(1): 329-345, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456890
9.
A New Classification of the Severity of Psoriasis: What's Moderate Psoriasis?
Life (Basel)
; 11(7)2021 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209585
10.
Intralesional corticosteroid injection for the treatment of hidradenitis suppurativa: a multicenter retrospective clinical study.
J Dermatolog Treat
; 32(3): 286-290, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402725
11.
Efficacy of dimethyl fumarate treatment for moderate-to-severe plaque psoriasis: presentation extracts from the 29th EADV virtual congress, 29-31 October 2020.
Expert Rev Clin Immunol
; 17(sup2): 1-11, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899642
12.
Cardiovascular risk factors influence response to biological therapies in psoriasis.
J Am Acad Dermatol
; 73(2): 327-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26183981
13.
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature.
Dermatol Ther (Heidelb)
; 10(4): 589-613, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529393
14.
Prolonged localized photosensitivity following allergic and photo-aggravated contact dermatitis from etofenamate.
Photodermatol Photoimmunol Photomed
; 30(6): 340-2, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25040936
15.
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting.
Int J Dermatol
; 62(3): e146-e149, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867958
16.
[Teledermatology in Paediatrics. Observations in daily clinical practice]. / Teledermatología en edad pediátrica. Observaciones en la práctica clínica diaria.
An Pediatr (Barc)
; 84(6): 324-30, 2016 Jun.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26271410
17.
Extraparietal or lymphatic late relapse of neoplasms: confirmation by means of EUS-FNA key for the treatment.
J Gastrointest Cancer
; 43(3): 490-5, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21104163
18.
Scrotal bullous pemphigoid in an elderly patient.
Int J Dermatol
; 53(9): e389-90, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24898442